Literature DB >> 10970368

Experimental model of progressive disseminated trichosporonosis in mice with latent trichosporonemia.

E Yamagata1, P Kamberi, Y Yamakami, A Hashimoto, M Nasu.   

Abstract

Trichosporon asahii and Trichosporon mucoides are the most common strains of fungi that cause disseminated trichosporonosis, a severe opportunistic infection in immunocompromised hosts. We have previously established a nested PCR assay using serum samples for detection of both strains. Here we describe a new experimental animal model for investigating the underlying mechanisms of disseminated trichosporonosis. T. asahii (OMU239, a clinical isolate from a patient with acute myelogenous leukemia) and 8-week-old ICR male mice were used in all experiments. A suspension of T. asahii (3 x 10(6) CFU/animal) was injected into the caudal vein of each mouse after immunosuppression with cyclophosphamide (200 mg/kg of body weight/day for 2 days) and prednisolone (30 mg/kg/day for 1 day). Mice were then divided into four subgroups (R0, R1, R2, and R3) based on the time of reimmunosuppression. The latter was performed using the same drugs 1 week (group R1), 2 weeks (group R2), and 3 weeks (group R3) after fungal infection. Reimmunosuppression was not performed in group R0. The 5-week-survival rates of mice after T. asahii infection were 0% for group R1, 50% for group R2, 80% for group R3, and 80% for group R0. There was a significant difference in the survival rates between group R1 and either group R0 or R3 (P < 0.05). Fungal clearance in peripheral blood and various organs of group R1 and R2 was delayed relative to that of group R0 but was similar to the control in group R3 in spite of reimmunosuppression. Our results suggest that the critical period for the development of disseminated trichosporonosis in our model is shorter than 3 weeks after T. asahii infection. We concluded that mice during this critical period were in a state of latent trichosporonemia. Comparison of the survival rates suggests that the nested PCR assay was more useful than blood culture and glucuronoxylomannan antigen assay in the detection of this latent trichosporonemia.

Entities:  

Mesh:

Year:  2000        PMID: 10970368      PMCID: PMC87371     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  25 in total

1.  Mouse model for disseminated Trichosporon beigelii infection.

Authors:  R M Bannatyne; I W Fong; P Cheng; J M Capellan
Journal:  Lab Anim Sci       Date:  1992-04

2.  Contributions to a revision of the genus Trichosporon.

Authors:  E Guého; M T Smith; G S de Hoog; G Billon-Grand; R Christen; W H Batenburg-van der Vegte
Journal:  Antonie Van Leeuwenhoek       Date:  1992-05       Impact factor: 2.271

3.  Disseminated Trichosporon beigelii infection causing skin lesions in a renal transplant patient.

Authors:  S H Mirza
Journal:  J Infect       Date:  1993-07       Impact factor: 6.072

Review 4.  Central catheter infection by Trichosporon beigelii after autologous blood stem cell transplantation. A case report and review of the literature.

Authors:  S Vasta; M Menozzi; R Scimé; A Indovina; A Speciale; G Liberti; C Spanò; I Majolino
Journal:  Haematologica       Date:  1993 Jan-Feb       Impact factor: 9.941

5.  A novel murine model of disseminated trichosporonosis.

Authors:  A Gokaslan; E Anaissie
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  PCR detection of DNA specific for Trichosporon species in serum of patients with disseminated trichosporonosis.

Authors:  H Nagai; Y Yamakami; A Hashimoto; I Tokimatsu; M Nasu
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Disseminated trichosporonosis in a neutropenic murine model.

Authors:  D Hospenthal; T Belay; P Lappin; A Rogers; M Kennedy
Journal:  Mycopathologia       Date:  1993-05       Impact factor: 2.574

Review 8.  Trichosporonosis in patients with neoplastic disease.

Authors:  T J Walsh; K R Newman; M Moody; R C Wharton; J C Wade
Journal:  Medicine (Baltimore)       Date:  1986-07       Impact factor: 1.889

9.  Experimental Trichosporon infection in persistently granulocytopenic rabbits: implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic mycosis.

Authors:  T J Walsh; J W Lee; G P Melcher; E Navarro; J Bacher; D Callender; K D Reed; T Wu; G Lopez-Berestein; P A Pizzo
Journal:  J Infect Dis       Date:  1992-07       Impact factor: 5.226

10.  Disseminated Trichosporon infection. A case report and immunohistochemical study.

Authors:  K Nasu; S Akizuki; K Yoshiyama; H Kikuchi; Y Higuchi; S Yamamoto
Journal:  Arch Pathol Lab Med       Date:  1994-02       Impact factor: 5.534

View more
  2 in total

1.  Experimental pathogenicity of a clinical isolate of Trichosporon dermatis in a murine model.

Authors:  Ying-Ping Lin; Yan-Ping Yang; Wen-Ming Huang; Yong-Hua Chen; Shun-Fan Li; Yi-Ming Fan
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

Review 2.  Fungal Bloodstream Co-infection by Trichosporon asahii in a COVID-19 Critical Patient: Case Report and Literature Review.

Authors:  Jéssica Louise Benelli; Rossana Patrícia Basso; Talita Werner Grafulha; Vanice Rodrigues Poester; Lívia Silveira Munhoz; Katheryne Benine Martins; Heruza Einsfeld Zogbi; Andrea Von Groll; Cecília Bittencourt Severo; David A Stevens; Melissa Orzechowski Xavier
Journal:  Mycopathologia       Date:  2022-06-04       Impact factor: 3.785

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.